Beroni Group Limited delivered an amended registration statement to the U.S. Securities & Exchange Commission this morning, advancing its plan to raise fresh capital by selling additional common stock. As previously shared with UV Reporter subscribers, the Australian company discloses its second-tier subsidiary Tianjin Beroni Biotechnology Co., Ltd. owns a utility patent, No. 201520673489.9, applied…
This content is viewable by members only. Visit MY ACCOUNT on the top menu to log in or to register for a 30 day free trial or purchase a subscription for UV Reporter 1 Year Single Membership or UV Reporter 1 Year Group Membership - $189 for first member and $25 for each additional member.
